Clinical Trials on Transradial-transfemoral Coronary Interventions Comparison in Taiwan
Total 8 results
-
Shenyang Northern HospitalUnknownPercutaneous Coronary InterventionChina
-
Far Eastern Memorial HospitalCompletedAcute STEMI | Primary Percutaneous Coronary Arterial InterventionTaiwan
-
Shanghai Zhongshan HospitalUnknownCoronary Artery Disease | Percutaneous Coronary InterventionChina
-
AstraZenecaCompletedAcute Coronary Syndrome | Percutaneous Coronary InterventionKorea, Republic of, Japan, Taiwan
-
Shenyang Northern HospitalCompletedPercutaneous Coronary Intervention | Acute Myocardial InfarctionChina
-
Janssen Scientific Affairs, LLCBayerCompletedAtrial Fibrillation | Percutaneous Coronary InterventionUnited States, France, Poland, Ukraine, United Kingdom, Belgium, Germany, Taiwan, Argentina, Mexico, Bulgaria, Malaysia, Romania, Russian Federation, South Africa, Turkey, Korea, Republic of, Australia, Canada, Netherlands, Denmark and more
-
Boehringer IngelheimCompletedAtrial Fibrillation | Percutaneous Coronary InterventionCanada, United States, Spain, Korea, Republic of, Australia, Germany, Taiwan, Hong Kong, Thailand, United Kingdom, Turkey, Netherlands, Ireland, Hungary, Croatia, Colombia, Israel, Singapore, Italy, New Zealand, Greece, Mexico, Norway, Swed... and more
-
Harbin Medical UniversityYangtze River Pharmaceutical Group Co., Ltd.RecruitingPercutaneous Coronary Intervention | ST-segment Elevation Myocardial Infarction (STEMI) | CardioprotectionChina